PSY155 - DETERMINING THE VALUE OF EMICIZUMAB (HEMLIBRA®) FOR THE PROPHYLAXIS TREATMENT OF HAEMOPHILIA A PATIENTS WITH INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Abstract
Authors
M.T. Álvarez I. Cuervo-Arango R. Perez-Santamarina J. Poveda J.A. Romero A. Santamaría J.L. Trillo M. Tort X. Badia